Cargando…
CD44s signals the acquisition of the mesenchymal phenotype required for anchorage-independent cell survival in hepatocellular carcinoma
BACKGROUND: Circulating tumour cells (CTCs) have an important role in metastatic processes, but details of their basic characteristics remain elusive. We hypothesised that CD44-expressing CTCs show a mesenchymal phenotype and high potential for survival in hepatocellular carcinoma (HCC). METHODS: Ci...
Autores principales: | Okabe, H, Ishimoto, T, Mima, K, Nakagawa, S, Hayashi, H, Kuroki, H, Imai, K, Nitta, H, Saito, S, Hashimoto, D, Chikamoto, A, Ishiko, T, Watanabe, M, Nagano, O, Beppu, T, Saya, H, Baba, H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3929866/ https://www.ncbi.nlm.nih.gov/pubmed/24300972 http://dx.doi.org/10.1038/bjc.2013.759 |
Ejemplares similares
-
miR-9-3p plays a tumour-suppressor role by targeting TAZ (WWTR1) in hepatocellular carcinoma cells
por: Higashi, T, et al.
Publicado: (2015) -
Effect of LSKL peptide on thrombospondin 1-mediated transforming growth factor β signal activation and liver regeneration after hepatectomy in an experimental model
por: Kuroki, H, et al.
Publicado: (2015) -
CD44 variant 9 expression in primary early gastric cancer as a predictive marker for recurrence
por: Hirata, K, et al.
Publicado: (2013) -
Significance of P-cadherin overexpression and possible mechanism of its regulation in intrahepatic cholangiocarcinoma and pancreatic cancer
por: Sakamoto, Keita, et al.
Publicado: (2015) -
The Number of Positive Tumor Marker Status Is Beneficial for the Selection of Therapeutic Modalities in Patients with Hepatocellular Carcinoma
por: Beppu, Toru, et al.
Publicado: (2017)